Dear all,
this thread seems a bit inconclusive to me. Obviously the participants don't entirely agree, yet maybe we could have some sort of an overview about the present state of topical DHT blockers (maybe even including 5-Alpha-reductase-inhibitors), something like: There's a) ………, b) ………, and c)……… as main substances that with some backup claim effect when used topically. A is backed up by this and this study, contradicted by this one. It is available in this and that product. B is … ?
I know it's a lot to ask, but I do feel a bit lost in all the quarrel, and I really am far from any expertise. And maybe there's hope that all disagreements at least will be collected and overviewed in such a list?
Certainly such a list would be of great interest to many, all those who seem to worry about the systemic side effects of non-topical application.
Thanks